L Lagares-Tena1, L Millán-Paredes1, L Lázaro-García1, A Navarro-Luna1, S Delgado-Rivilla1, A Muñoz-Duyos2. 1. Unit of Colorectal Surgery, Department of General Surgery, Hospital Universitari MútuaTerrassa, University of Barcelona, Plaça Dr. Robert, 5, 08221, Terrassa, Barcelona, Spain. 2. Unit of Colorectal Surgery, Department of General Surgery, Hospital Universitari MútuaTerrassa, University of Barcelona, Plaça Dr. Robert, 5, 08221, Terrassa, Barcelona, Spain. amduyos@gmail.com.
Abstract
BACKGROUND: The aim of the present study was to evaluate the effectiveness of sacral neuromodulation (SNM) as a treatment for congenital faecal incontinence (FI). METHODS: A retrospective study was conducted on patients with congenital FI who had SNM surgery at our institution between October 2005 and June 2013. An initial percutaneous nerve evaluation was performed, and patients with an improvement of more than 50% in their symptoms had permanently implants for SNM treatment. RESULTS: There were 4 patients who received a permanent implant. Mean duration of follow-up was 67.5 months (range 45-135 months). At last follow-up, 2 patients maintained significant improvement with SNM, 1 was explanted after 4 years of treatment due to infection but remained asymptomatic and SNM failed in the remaining patient who went on to graciloplasty. CONCLUSIONS: SNM may be of value for treating FI in patients with anorectal malformations.
BACKGROUND: The aim of the present study was to evaluate the effectiveness of sacral neuromodulation (SNM) as a treatment for congenital faecal incontinence (FI). METHODS: A retrospective study was conducted on patients with congenital FI who had SNM surgery at our institution between October 2005 and June 2013. An initial percutaneous nerve evaluation was performed, and patients with an improvement of more than 50% in their symptoms had permanently implants for SNM treatment. RESULTS: There were 4 patients who received a permanent implant. Mean duration of follow-up was 67.5 months (range 45-135 months). At last follow-up, 2 patients maintained significant improvement with SNM, 1 was explanted after 4 years of treatment due to infection but remained asymptomatic and SNM failed in the remaining patient who went on to graciloplasty. CONCLUSIONS: SNM may be of value for treating FI in patients with anorectal malformations.
Authors: A L A Bloemendaal; K Gorissen; S Prapasrivorakul; O M Jones; R Hompes; C Cunningham; I Lindsey Journal: Int J Colorectal Dis Date: 2015-06-14 Impact factor: 2.571
Authors: D F Altomare; S Giuratrabocchetta; C H Knowles; A Muñoz Duyos; J Robert-Yap; K E Matzel Journal: Br J Surg Date: 2015-02-02 Impact factor: 6.939
Authors: Urte Zurbuchen; Joern Groene; Susanne D Otto; Martin E Kreis; Stefanie Maerzheuser Journal: Int J Colorectal Dis Date: 2014-07-05 Impact factor: 2.571